CNS Drugs

, Volume 3, Issue 3, pp 186–193 | Cite as

Primary Dystonias

Current Therapeutic Recommendations
  • Carlos Singer
  • William J. Weiner
Practical Therapeutics


Dystonia is a syndrome of sustained muscle contractions, frequently causing twisting and repetitive movements or abnormal postures. Primary and secondary dystonias are distinguishable and both can be classified by the extent of body involvement as generalised, focal, segmental, multifocal and hemidystonic. The treatment of primary dystonias involves the exclusion of secondary causes such as drug-induced (particularly common with dopamine blocking agents) and Wilson’s disease. This should be followed by a trial of levodopa, especially in cases of onset in the first 3 decades of life.

Symptomatic oral pharmacotherapy includes anticholinergic agents, baclofen, clonazepam and carbamazepine. The use of intrathecal baclofen infused by a surgically implanted pump has been advocated for intractable axial dystonia. Botulinum toxin A injections have become the treatment of choice of many focal dystonias (e.g. blepharospasm, cervical dystonia, jaw closure dystonia, hyper-adduction laryngeal dystonia). Jaw opening dystonia, writer’s cramp and more complex limb dystonias may also benefit from botulinum toxin A. Paroxysmal kinesigenic dystonias are responsive to phenytoin, carbamazepine, phenobarbital (phenobarbitone), primidone and diazepam. Paroxysmal nonkinesigenic dystonias do not respond as well to these agents and may warrant a trial of other agents such as acetazolamide, clonazepam, oxazepam, baclofen or anticholinergic agents.

Surgical interventions include stereotactic thalamotomy for severe generalised dystonia unresponsive to intensive pharmacological trials, and ‘peripheral’ surgeries designed to address specific types of focal dystonia that are unresponsive to botulinum toxin (e.g. orbital myectomy for blepharospasm and cervical ramisectomy for cervical dystonia). Orthotic devices for limb dystonia, and writing aid devices and other physical therapy measures can provide assistance in selected patients.


Levodopa Dystonia Botulinum Toxin Baclofen Clonazepam 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wilson’s disease. In: Wiener WJ, Lang AE. Movement disorders: a comprehensive survey. Mount Kisco, NY: Future Publishing Co. Inc., 1989: 257-91Google Scholar
  2. 2.
    Segawa M, Hosaka A, Miyagawa F, et al. Hereditary progressive dystonia with marked diurnal fluctuations. Adv Neurol 1976; 14: 215–33PubMedGoogle Scholar
  3. 3.
    Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Adv Neurol 1988; 50: 377–84PubMedGoogle Scholar
  4. 4.
    Nygaard TG, Marsden CD, Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 1991; 41: 174–81PubMedCrossRefGoogle Scholar
  5. 5.
    Fletcher NA, Thompson PD, Scadding JW, et al. Successful treatment of childhood onset symptomatic dystonia with levodopa. J Neurol Neurosurg Psychiatry 1993; 56: 865–7PubMedCrossRefGoogle Scholar
  6. 6.
    Greene P, Shale H, Fahn S. Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Mov Disord 1988; 3: 46–60PubMedCrossRefGoogle Scholar
  7. 7.
    Green PE, Fahn S. Baclofen in the treatment of idiopathic dystonia in children. Mov Disord 1992; 7: 48–52CrossRefGoogle Scholar
  8. 8.
    Narayan RK, Loubser PG, Jankovic J, et al. Intrathecal baclofen for intractable dystonia. Neurology 1991; 41: 1141–2PubMedCrossRefGoogle Scholar
  9. 9.
    Brin MF, Sadiq S, Goodman R, et al. Intrathecal baclofen (IT-B) for dystonia [abstract]. Neurology 1994; 44 Suppl. 2: A338Google Scholar
  10. 10.
    Isgreen WP, Fahn S, Barrett RE, et al. Carbamazepine in torsion dystonia. Adv Neurol 1976; 14: 411–6PubMedGoogle Scholar
  11. 11.
    Garp BP. Dystonia musculorum deformans: implications of therapeutic response to levodopa and carbamazepine. Arch Neurol 1982; 39: 376–7CrossRefGoogle Scholar
  12. 12.
    Newman RP, LeWitt PA, Shults C, et al. Dystonia: treatment with bromocriptine. Clin Neuropharmacol 1985; 8: 328–33PubMedCrossRefGoogle Scholar
  13. 13.
    Girotti F, Scigliano G, Nardocci N, et al. Idiopathic dystonia: neuropharmacological study. J Neurol 1982; 227: 239–47PubMedCrossRefGoogle Scholar
  14. 14.
    Burke RE, Fahn S, Jankovic J, et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982; 32: 1335–46PubMedCrossRefGoogle Scholar
  15. 15.
    Jankovic J, Orman J. Tetrabenazine therapy of dystonia, chorea, tics and other dyskinesias. Neurology 1988; 38: 391–4PubMedCrossRefGoogle Scholar
  16. 16.
    Jankovic J, Schwartz KS. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology 1993; 43: 834–6PubMedCrossRefGoogle Scholar
  17. 17.
    Blitzer A, Brin MF. Laryngeal dystonia: a series with botulinum toxin therapy. Ann Otol Rhinol Laryngol 1991; 100: 85–9PubMedGoogle Scholar
  18. 18.
    Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990; 53: 633–9PubMedCrossRefGoogle Scholar
  19. 19.
    Jankovic J, Schwartz KS. Use of botulinum toxin in treatment of hand dystonia. J Hand Surg 1993; 18: 883–7CrossRefGoogle Scholar
  20. 20.
    Sanders DB, Massey EW, Buckley EC. Botulinum toxin for blepharospasm: single fiber EMG studies. Neurology 1986; 36: 545–7PubMedCrossRefGoogle Scholar
  21. 21.
    Jankovic J, Schwartz KS. Clinical correlates of response to botulinum toxin injections. Arch Neurol 1991; 324: 1186–94Google Scholar
  22. 22.
    Bressman SB, Fahn S, Burke RE. Paroxysmal non-kinesogenic dystonia. Adv Neurol 1988; 50: 403–13PubMedGoogle Scholar
  23. 23.
    Andrew J, Fowler CJ, Harrison MJ. Stereotaxic thalamotomy in 55 cases of dystonia. Brain 1983; 106: 981–1000PubMedCrossRefGoogle Scholar
  24. 24.
    Tasker RR, Doorly T, Yamashiro K. Thalamotomy in generalized dystonia. Adv Neurol 1988; 50: 615–31PubMedGoogle Scholar
  25. 25.
    Hurvitz EA, Ellenberg MR, Lupo R, et al. Orthotic technique for dystonia musculorum deformans. Arch Phys Med Rehabil 1988; 69: 892–4PubMedGoogle Scholar
  26. 26.
    Ranayawa R, Lang AE. Usefulness of a writing device in writer’s cramp. Neurology 1991; 41: 1136–8CrossRefGoogle Scholar

Copyright information

© Adis International Limited 1995

Authors and Affiliations

  • Carlos Singer
    • 1
  • William J. Weiner
    • 1
  1. 1.Department of NeurologyUniversity of Miami School of MedicineMiamiUSA

Personalised recommendations